Results

Total Results: 41 records

Showing results for "reason".

1. Cap 3 Decidexecut
   cds.ahrq.gov/sites/default/files/cds/artifact/396/cap_3_DecidExecut.html
   January 01, 1970 - Evidence Quality: Level 1 Strength of Recommendation: Strong Reason: Logic: Cost:     Imperative: Objective … Strength of Recommendation: Moderate recommendation Reason: Logic: If patients with CURB-65 scores ≥ … Strength of Recommendation: Strong recommendation; Reason: Logic:     Conditional: Direct admission to … Strength of Recommendation: Strong recommendation; Reason: Logic:     Imperative: Routine diagnostic … Strength of Recommendation: Moderate recommendation; Reason: Logic: Cost:

2. Apr-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
   January 01, 2017 - . · QIP did not use the original NCQA value set for this reason. … The provider can then document the reason why the med (i.e., aspirin) is not ordered OR close the box … if they don’t want to document the reason.

3. Occupational Factors Which Impact Diabetes, A Final Knowledge Resource Report (2015) (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
   January 01, 2015 - the receptionist whether she has diabetes or send her for a medical examination because he has a reason … If leave for this length of time and/or for this reason would not be allowed under an existing leave … Because there is no reason to believe that the actor poses a direct threat, the director cannot terminate … For this reason employers may want to include a warning in the request for documentation that the employee

4. May-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/236/may-2017-cholesterol-wg-notes.docx
   January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 05/09/2017 Time 5:00 – 7:00 PM EST AGENDA · Welcome · Gather Feedback on Lookback Periods, Notifications for the USPSTF Artifacts and Value Sets · CDS Connect Pilot Overview · Statin CDS Demos: Options for Providing CDS Notifications · Next Ste…

5. Jan-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
   January 01, 2017 - For this reason, the USPTF recommendation to calculate ASCVD risk only when 1 or more risk factor is

6. June 2021 CDS Connect Work Group Slides (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdf
   January 01, 2021 - Modified from: James Reason, Human Error, 1990 Prescribers’ PDDI Knowledge Prescriber knowledge is

7. 2024 Data Requirements T2Dm Part Two 0 (xls file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_Data_Requirements_T2DM_Part_Two_0.xlsx
   January 01, 2024 - 2.16.840.1.113762.1.4.1032.307 Behavioral Counseling for Nutrition and Activity Encounter Encounter status is not 'cancelled' reason

8. 2024 Data Requirements Statin Cvd Patient Facing (xls file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_Data_Requirements_Statin_CVD_Patient_Facing.xlsx
   January 01, 2024 - 2.16.840.1.113883.3.526.3.353 End Stage Renal Disease Encounter Encounter status is 'in-progress' or 'finished' reason

9. Jun-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
   January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 06/21/2017 Time 1:30 – 2:45 PM EST AGENDA · Welcome and Review of Agenda · Gather Feedback on Additional Details Required to Support Development of the eCQM Artifact · Next Steps and Closing · SUMMARY Welcome CAMH welcomed the WG Members to the Jun…

10. Feb-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 02/08/2017 Time 1:30 – 3:30 PM ET AGENDA · Welcome · Discuss Remaining Repository Questions · Clarify 10-Year Risk Assessment Details · Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact · Discuss Next Artifacts for Developmen…

11. 2024 Data Requirements Healthy Diet And Physical Activity (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_Data_Requirements_Healthy_Diet_and_Physical_Activity.xlsx
    January 01, 2024 - 2.16.840.1.113762.1.4.1032.307 Behavioral Counseling for Nutrition and Activity Encounter Encounter status is not 'cancelled' reason

12. Dec-2016-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - For this reason, CMS64 may be out of date since it prompts treatment against LDL goals instead of against

13. Title of document or resource (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Title of document or resource Repository Work Group Meeting Summary Date 03/08/2017 Time 1:30 – 3:30 PM ET AGENDA · Clarify Details Related to Existing Artifacts · Logic exclusions, specification of conditions, lookback periods and the inclusion of parameters for scalar values · Considerations for art…

14. Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD): An Electronic Clinical Quality Measure (eCQM)-derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - muscle symptoms, who have end-stage renal disease (ESRD), or who have documentation of a medical reason … • Patients with documentation of a medical reason for not being prescribed statin therapy. … difference between eCQM and CDS logic The eCQM logic excepts “[p]atients with documentation of a medical reason

15. Guide To The Healthy Weight Care Assistant (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/106/Guide%20to%20the%20Healthy%20Weight%20Care%20Assistant.docx
    February 15, 2018 - Guide to the Healthy Weight Care Assistant 1. Introduction The Healthy Weight Care Assistant (HWCA) was developed to assist pediatricians in providing evidence-based care to children with overweight or obese body habitus who were at risk for developing complications of obesity. The goal was that by early identification…

16. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - Part of the reason for using standard value sets is that they are maintained and keep up with changing … Request medication order Document new medications on the medication list Document reason for not

17. CDS Connect Pilot Final Report (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
    March 01, 2018 - An additional reason clinicians shared for augmenting or ignoring the pilot CDS was the lack of reliability

18. CDS Connect Pilot Final Report Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
    September 01, 2018 - The primary reason cited was the lag time experienced by the clinicians in the launch of the Summary

19. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - Impaired renal function may influence statin safety.25 For this reason, evidence of ESRD is listed as … Impaired hepatic function may influence statin safety.25 For this reason, evidence of cirrhosis is expressed … Encounter X Encounter status is ‘in-progress,’ ‘finished’ (DSTU2 only), or ‘completed’ (R4 only) reason

20. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - Impaired renal function may influence statin safety.4 For this reason, evidence of ESRD is listed as … Impaired hepatic function may influence statin safety.22 For this reason, evidence of cirrhosis is expressed